Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Viral Vectors, AAV

Luk Vandenberghe

PhD

🏢Massachusetts Eye and Ear, Harvard Medical School🌐USA

Grousbeck Family Chair in Gene Therapy; Director, Grousbeck Gene Therapy Center

60
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Luk Vandenberghe is a leader in AAV capsid engineering and directs the Grousbeck Gene Therapy Center at Mass Eye and Ear. His laboratory has developed novel AAV capsids for ocular and systemic gene therapy. He co-founded Affinia Therapeutics to translate capsid engineering into cancer and genetic disease therapies.

Share:

🧪Research Fields 研究领域

AAV capsid engineering
ocular gene therapy
AAV evolution
vector immunology
cancer vector design

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Luk Vandenberghe 的研究动态

Follow Luk Vandenberghe's research updates

留下邮箱,当我们发布与 Luk Vandenberghe(Massachusetts Eye and Ear, Harvard Medical School)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment